- Home
- STTK vs HFFG Comparison
STTK vs HFFG Comparison
Compare STTK & HFFG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STTK
- HFFG
- Stock Information
- Founded
- STTK 2016
- HFFG 1997
- Country
- STTK United States
- HFFG United States
- Employees
- STTK N/A
- HFFG N/A
- Industry
- STTK Biotechnology: Pharmaceutical Preparations
- HFFG Food Distributors
- Sector
- STTK Health Care
- HFFG Consumer Discretionary
- Exchange
- STTK Nasdaq
- HFFG Nasdaq
- Market Cap
- STTK 37.6M
- HFFG 208.3M
- IPO Year
- STTK 2020
- HFFG N/A
- Fundamental
- Price
- STTK $0.83
- HFFG $3.34
- Analyst Decision
- STTK Hold
- HFFG
- Analyst Count
- STTK 4
- HFFG 0
- Target Price
- STTK $3.00
- HFFG N/A
- AVG Volume (30 Days)
- STTK 401.7K
- HFFG 70.3K
- Earning Date
- STTK 07-31-2025
- HFFG 08-05-2025
- Dividend Yield
- STTK N/A
- HFFG N/A
- EPS Growth
- STTK N/A
- HFFG N/A
- EPS
- STTK N/A
- HFFG N/A
- Revenue
- STTK $4,606,000.00
- HFFG $1,204,441,000.00
- Revenue This Year
- STTK N/A
- HFFG $4.27
- Revenue Next Year
- STTK N/A
- HFFG $4.47
- P/E Ratio
- STTK N/A
- HFFG N/A
- Revenue Growth
- STTK 69.65
- HFFG 4.71
- 52 Week Low
- STTK $0.69
- HFFG $1.70
- 52 Week High
- STTK $4.99
- HFFG $4.93
- Technical
- Relative Strength Index (RSI)
- STTK 39.19
- HFFG 45.23
- Support Level
- STTK $0.77
- HFFG $3.03
- Resistance Level
- STTK $0.91
- HFFG $3.38
- Average True Range (ATR)
- STTK 0.08
- HFFG 0.20
- MACD
- STTK -0.02
- HFFG 0.02
- Stochastic Oscillator
- STTK 16.23
- HFFG 51.64
About STTK Shattuck Labs Inc.
Shattuck Labs Inc is a biotechnology company specializing in the development of potential treatments for inflammatory and immune-mediated diseases. It is developing a potentially first-in-class antibody for the treatment of inflammatory bowel disease (IBD) and other inflammatory and immune-mediated diseases. The company's expertise in protein engineering and the development of novel tumor necrosis factor (TNF) receptor therapeutics comes together in its main program, SL-325, which has the potential to be a first-in-class death receptor 3 (DR3) antagonist antibody. In addition, the company is developing SL-425, a half-life extended version of SL-325, and multiple other preclinical DR3-based bispecific antibodies, for the treatment of patients with IBD.
About HFFG HF Foods Group Inc.
HF Foods Group Inc is an Asian food service distributor that markets and distributes fresh produce, seafood, frozen and dry food, and non-food products to Asian restaurants and other food service customers throughout the United States. The company's business consists of one operating segment; HF Group, which operates solely in the United States. The company's customer base consists of Chinese and Asian restaurants, and it provides sales and service support to customers who mainly converse in Mandarin or Chinese dialects.